EPISODE · Jul 30, 2026 · 30 MIN
1356-ADC精准医疗：挑战、进展与未来路径
from 聊聊Sci
这篇文章系统探讨了抗体偶联药物（ADC）在精准肿瘤学领域的发展现状。文中详细分析了当前研发面临的核心障碍，例如肿瘤内部的抗原异质性、复杂的药代动力学以及耐药机制的产生。为了克服这些局限，研究者提出应整合多维度生物标志物，并结合机器学习模型来优化患者筛选策略。此外，资料还讨论了通过双抗设计和联合免疫疗法来增强药效，以期在早期疾病阶段实现更佳的安全性与临床收益。最后，大量针对乳腺癌、肺癌和胰腺癌的临床试验数据，为构建下一代个体化治疗方案提供了重要支撑。References:Pistilli B, Colombo R, Mosele M F, et al. Antibody-drug conjugates in precision oncology[J]. Cancer Cell, 2026, 44(6): 1126-1146.前往小宇宙评论区与主播互动
Embed this episode
NOW PLAYING
1356-ADC精准医疗：挑战、进展与未来路径
0:00
30:36
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 聊聊Sci?
This episode is 30 minutes long.
When was this 聊聊Sci episode published?
This episode was published on July 30, 2026.
Can I download this 聊聊Sci episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!